Business
GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% CHICAGO--(BUSINESS WIRE)--
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"\nCompany updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17%\n\n\n CHICAGO--(BUSINESS WIRE)--\nGE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here. Registration is required for in-person attendance.\n\n\nThe event will feature presentations from GE HealthCare President and CEO Peter Arduini, GE HealthCare Vice President and CFO Jay Saccaro, and other members of the management team, who will discuss the company’s vision and precision care strategy, progress since its spin-off from General Electric Company in 2023, and key growth areas. A technology showcase will follow the presentations for in-person attendees.\n\n\nGE HealthCare President and CEO Peter Arduini said, “We are confident in our progress since spin and our path to accelerate growth driven by an exciting innovation pipeline. We look forward to continuing to execute on our growth strategy to help clinicians provide more precise, personalized care for patients, delivering on our purpose to create a world where healthcare has no limits.”\n\n\nGE HealthCare Vice President and CFO Jay Saccaro said, “Our resilient business model positions us well on our medium-term trajectory. In particular, we have made excellent progress expanding our margins with clear line of sight to delivering additional upside in the future. We are also delighted to announce that we are increasing our quarterly dividend by approximately 17%, which reflects confidence in our business.”\n\n\nMembers of the GE HealthCare leadership team will discuss how the company plans to drive growth and deliver on its precision care strategy, including:\n\n\n\nFinancial and operational progress since spin\n\n\n\nGrowth opportunities across the Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments\n\n\n\nA robust pipeline of innovation driven by significant research and development investments, with a focus on disease states to address key healthcare challenges\n\n\n\nAdvancements in its cloud-first, AI and digital strategy focused on AI on device, at the department level, and across the enterprise\n\n\n\nRadiopharmaceutical growth opportunities with proprietary molecules...